The global erectile dysfunction drugs market is led by North America and the region will continue to maintain its leading position during the forecast period owing to the presence of major erectile dysfunction drugs such as Viagra and Cialis.
The erectile dysfunction drugs market report offers an insightful and in-depth assessment of the structure and various elements of the erectile dysfunction drugs market. The report provides a comprehensive introduction of the market, together with industry history, product and geographical classification, and value chain analysis. Key aspects such as production, supply and consumption analysis, price cost and profit evaluation, growth drivers and inhibitors, and details regarding imports and exports have been provided in the erectile dysfunction drugs report with critical insights and recommendations.

Overview of the global erectile dysfunction drugs market

The worldwide erectile dysfunction drugs market is primarily driven by growing geriatric population, rise in incidences of numerous diseases, preference towards sedentary lifestyle, and increasing focus on patient education and awareness. In addition to this, the growing impact of generics, ongoing clinical trials and tests for erectile dysfunction drugs, blockbuster patent expirations, innovative drug delivery techniques, and new molecule combinations are some of the areas that hold immense growth opportunities for the erectile dysfunction drugs market.

On the other hand, diminishing insurance coverage for the treatment of erectile dysfunction, increasing threat from counterfeit drugs, weak pipeline development, and increasing prevalence of sexually transmitted diseases (STDs) among users of erectile dysfunction drugs are expected to hamper the growth of the market. Moreover, the expectant patent expiration of Eli Lilly & Co.’s Cialis and Bayer AG’s Levitra, and that of industry leader Pfizer’s Viagra outside the U.S. in 2013 is estimated to greatly impact the erectile dysfunction drugs market.

Requesting For Sample : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1550

Geographically, North America led the global erectile dysfunction drugs market and was estimated to be worth US$2,098.4 million in 2012. While patent expiration of blockbuster erectile dysfunction drugs is expected to restrain the growth of the erectile dysfunction drugs market in developed regions, their increasing adoption in emerging economies is expected to drive the global erectile dysfunction drugs market.

Companies mentioned in the research report

The research report on erectile dysfunction drugs market profiles the leading players operating in the market. Highlighting individual strengths, weakness, opportunities, and threats, the report offers a detailed analysis on the various participants in the erectile dysfunction drugs market. It also tracks and anticipates numerous trends and developments in the competitive landscape and offers critical and strategic recommendations based on data provided by authentic sources within the erectile dysfunction drugs market. The companies mentioned in the erectile dysfunction drugs market report are Meda Pharmaceuticals, Inc., Cristalia Produtos Quimicos Farmaceuticos Ltda., Vivus, Inc., Eli Lilly And Company, Apricus Biosciences, Inc., Dong-A Pharmaceutical Co. Ltd., Pfizer, Inc., S.K. Chemicals Co. Ltd., and Bayer AG.

Click Here For Upcoming Report : http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

Among these, Viagra by Pfizer, Inc. dominated the erectile dysfunction drugs market in 2012, followed by Eli Lilly & Co.’s Cialis and Bayer AG’s Levitra.

Major geographies analyzed under this research report are:
EMEA
North America
Asia-Pacific
Rest of the World
This report gives you access to decisive data such as:
Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for the coming years
Key highlights of this report
Overview of key market forces propelling and restraining market growth
Up-to-date analyses of market trends and technological improvements
Pin-point analyses of market competition dynamics to offer you a competitive edge
An analysis of strategies of major competitors
An array of graphics and SWOT analysis of major industry segments
Detailed analyses of industry trends
A well-defined technological growth map with an impact-analysis
Offers a clear understanding of the competitive landscape and key product segments